The table below shows a summary of project locations, supervisors and secondments.
Project No. | Host location | PI’s | Secondments | Project Title |
---|---|---|---|---|
1 |
University of Birmingham, UK ***CLOSED for applications |
Professor Steve Watson & Dr Natalie Poulter (Birmingham) , Prof Benhard Nieswandt (Wuerzburg) |
Dr Antonija Begonja, University of Rijeka, Croatia | Regulation of GPVI clustering: role of the cytoskeleton |
2 | University of Birmingham, UK ***CLOSED for applications |
Professor Steve Watson & Dr Mike Tomlinson (Birmingham), Dr Angel Garcia (Santiago) |
Albert Sickmann and Robert Ahrends (Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V., Germany) | The role of membrane microdomains in GPVI signalling |
3 | Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. Germany ***CLOSED for applications |
Professor Albert Sickmann (ISAS), Professor Johan Heemskerk & Professor Hugo ten Cate (Maastricht), Dr Angel Garcia (Santiago). |
Professor Albert Sickmann, Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V., Germany | Innovative methods to study proteomic signatures of glycoprotein receptor signalling |
4 | Universiteit Maastricht, The Netherlands ***CLOSED for applications |
Professor Johan Heemskerk & Dr Yvonne Henskens (Maastricht) Dr Natalie Poulter & Professor Steve Watson (Birmingham) |
Dr Dmitry Kashani, Cellix, Republic of Ireland | Role of (patho)physiological flow on receptor clustering and signalling |
5 |
The University of Reading, UK ***CLOSED for applications |
Dr Alice Pollitt & Jon Gibbins (Reading), Dr Angel Garcia (Santiago) |
Dr Helma Rutjes, Pivot Park Screening Centre, The Netherlands | Artificial lipid membranes to study GPVI receptor clustering and signalling |
6 | Universiteit Maastricht, The Netherlands ***CLOSED for applications | Paola van der Meijden and Hugo ten Cate (School for Cardiovascular Diseases, Maastricht University, NL), Jon Gibbins and Chris Jones (University of Reading, UK) | Dr Jolan Harsfalvi, Semmelweis University, Budapest, Hungary | Contribution of coagulation to clot formation via clustering and signaling of platelet receptors |
7 | Universitaetsklinikum Wuerzburg, Germany ***CLOSED for applications | David Stegner (University of Würzburg, Germany), Steve Thomas and Steve Watson (University of Birmingham, UK) | Professor Johan Heemskerk, Universiteit Maastricht, The Netherlands | The role of platelet receptors in inflammatory bleeding |
8 | Universiteit Maastricht, The Netherlands ***CLOSED for applications | Paola van der Meijden and Johan Heemskerk (Maastricht University, NL), Jon Gibbins and Chris Jones (University of Reading, UK) | Professor Albert Sickmann, Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. | Vessel-on-a-chip as novel model to assess receptor function in thrombosis and haemostasis |
9 | Alacris Theranostics GmbH, Germany ***CLOSED for applications | Natalie Poulter and Steve Watson (Birmingham, UK), Prof Bernhard Nieswandt (University of Würzburg, Germany) | Bodo Lange and Christoph Wierling (Alacris Theranostics GmbH, Berlin, Germany) | Modelling of CLEC-2 clustering and signalling |
10 | University of Reading, UK ***CLOSED for applications | Jon Gibbins and Marcus Tindall (University of Reading, UK), Johan Heemskerk and Marijke Kuijpers, (Maastricht University, Netherlands). | Bodo Lange and Christoph Wierling (Alacris Theranostics GmbH, Berlin, Germany) | Modelling of collagen receptor clustering and signalling |
11 | Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V., Germany ***CLOSED for applications | Steve Watson (University of Birmingham, UK); Johan Heemskerk and Rachel Cavill (School for Cardiovascular Diseases, Maastricht University, NL) | Robert Ahrends and Albert Sickmann (ISAS, Dortmund, DE), & Dr Bodo Lang, Alacris Theranostics GmbH, Germany | Integrating omics, functional datasets and microscopy to predict thrombosis and haemostasis |
12 | Universiteit Maastricht, The Netherlands – ***CLOSED for applications | Marijke Kuijpers and Johan Heemskerk (School for Cardiovascular Diseases Maastricht University, NL), Ángel García (University of Santiago de Compostela, SP) | Dr. Helma Rutjes, Pivot Park Screening Centre, The Netherlands | High throughput screening of small molecule inhibitors of receptor signalling |
13 | University of Reading, UK ***CLOSED for applications | Craig Hughes and Jon Gibbins (University of Reading, UK), Bernhard Nieswandt and David Stegner (University of Würzburg, Germany) | Dr. Helma Rutjes, Pivot Park Screening Centre, The Netherlands | Generation and functional testing of novel biologics targeting glycoprotein receptors |
14 | Universitaetsklinikum Wuerzburg, Germany ***CLOSED for applications | Bernhard Nieswandt and Attila Braun (University of Würzburg, Germany), Johan Heemskerk and Marijke Kuijpers (CARIM, University of Maastricht, The Netherlands) | CRISPR/Cas9 based generation of genetic mouse models to assess platelet receptor targeting | |
15 | Universidad de Santiago de Compostela, Spain ***CLOSED for applications | Ángel García (University of Santiago, Spain); Steve Watson and Mike Tomlinson (University of Birmingham, UK) | Dr. Helma Rutjes, Pivot Park Screening Centre, The Netherlands | High throughput screening of small molecule inhibitors of CLEC-2 |